Renal Effects of Combination Phosphodiesterase V Inhibition and Low-Dose B-Type Natriuretic Peptide in Acute Heart Failure: A Randomized Clinical Trial
Authors
Scott Hubers (ORCID: https://orcid.org/0000-0001-8129-2452)
Sherry L. Benike
Bradley K. Johnson (ORCID: https://orcid.org/0000-0002-9005-3434)
Christopher G. Scott (ORCID: https://orcid.org/0000-0003-1340-0647)
Horng H. Chen (ORCID: https://orcid.org/0000-0002-2315-0330)
Paul M. McKie (ORCID: https://orcid.org/0000-0003-0019-4768)
Georgia Clinical and Translational Science Alliance
National Institutes of Health
National Heart, Lung, and Blood Institute
National Center for Research Resources
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Renal Effects of Combination Phosphodiesterase V Inhibition and Low-Dose B-Type Natriuretic Peptide in Acute Heart Failure: A Randomized Clinical Trial
Scott Hubers, Sherry L. Benike, Bradley K. Johnson, Christopher G. Scott et al.
Citations
1 citations
Journal
Circulation Heart Failure
Topics
Heart Failure Treatment and Management
Field-Weighted Citation Impact (FWCI)
0.40
article
Renal Effects of Combination Phosphodiesterase V Inhibition and Low-Dose B-Type Natriuretic Peptide in Acute Heart Failure: A Randomized Clinical Trial
Scott Hubers, Sherry L. Benike, Bradley K. Johnson, Christopher G. Scott, Horng H. Chen, Paul M. McKie
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Circulation Heart FailureVol. 17(12)
Institutions
Mayo Clinic (US), Mayo Clinic in Arizona (US), Minneapolis Heart Institute Foundation (US), Mayo Clinic in Florida (US)
Funders
Georgia Clinical and Translational Science Alliance, National Institutes of Health, National Heart, Lung, and Blood Institute, National Center for Research Resources